Integra LifeSciences (IART) News Today $19.58 +0.01 (+0.05%) Closing price 04:00 PM EasternExtended Trading$19.59 +0.01 (+0.05%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Wellington Management Group LLP Reduces Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Wellington Management Group LLP lowered its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 77.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,506,138 shares ofApril 7 at 4:12 AM | marketbeat.comAlliancebernstein L.P. Lowers Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Alliancebernstein L.P. reduced its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 14.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,578,393 shares of theApril 7 at 4:11 AM | marketbeat.com15,100 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by KLP Kapitalforvaltning ASKLP Kapitalforvaltning AS purchased a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 15,100 shares of the life sciences company's sApril 7 at 3:18 AM | marketbeat.comPrudential Financial Inc. Lowers Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)Prudential Financial Inc. lessened its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 57.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 88,121 shares of the life sciencesApril 6 at 3:35 AM | marketbeat.comRaymond James Financial Inc. Invests $943,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART)Raymond James Financial Inc. bought a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 41,592April 6 at 3:07 AM | marketbeat.comBrokerages Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Target Price at $23.00April 3, 2025 | americanbankingnews.com156,746 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by Cannell & Spears LLCCannell & Spears LLC acquired a new stake in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 156,746 shares of the life sciences company's stock, valued at approximately $3,555,0April 2, 2025 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Rating of "Reduce" by AnalystsShares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Get Free Report) have earned a consensus rating of "Reduce" from the eight ratings firms that are presently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a sell rating, four have issuedApril 1, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Stock Rating Upgraded by ArgusArgus upgraded Integra LifeSciences from a "hold" rating to a "buy" rating in a research report on Monday.April 1, 2025 | marketbeat.comArgus upgrades Integra to Buy, says well-positioned for a turnaroundApril 1, 2025 | markets.businessinsider.comIntegra LifeSciences upgraded to Buy from Hold at ArgusApril 1, 2025 | markets.businessinsider.comArgus Research Upgrades Integra LifeSciences Holdings (IART)April 1, 2025 | msn.comIntegra LifeSciences (NASDAQ:IART) Upgraded at ArgusApril 1, 2025 | americanbankingnews.comIntegra LifeSciences Holdings C (IART) Stock ForecastsApril 1, 2025 | finance.yahoo.comQuantbot Technologies LP Sells 64,470 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Quantbot Technologies LP reduced its holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 89.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 7,881 shares of the life sciences company's stock after selling 64,470March 31, 2025 | marketbeat.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Shares Purchased by Thrivent Financial for LutheransThrivent Financial for Lutherans raised its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 70.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 93,427 shares of the life sciences compMarch 30, 2025 | marketbeat.comIntegra (IART) Down 7.5% Since Last Earnings Report: Can It Rebound?March 27, 2025 | msn.comIntech Investment Management LLC Has $547,000 Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Intech Investment Management LLC lifted its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 86.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 24,113 shares of thMarch 25, 2025 | marketbeat.comQ4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)March 24, 2025 | msn.comNotice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your BehalfMarch 22, 2025 | globenewswire.comIntegra LifeSciences (NASDAQ:IART) Shares Down 2.9% - Here's What HappenedIntegra LifeSciences (NASDAQ:IART) Trading Down 2.9% - Here's WhyMarch 20, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Decreases Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART)Connor Clark & Lunn Investment Management Ltd. lessened its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 76.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5March 20, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Increases Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)Charles Schwab Investment Management Inc. increased its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 10.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,047,573 shareMarch 19, 2025 | marketbeat.com3 Reasons IART is Risky and 1 Stock to Buy InsteadMarch 14, 2025 | msn.comIntegra LifeSciences Holdings Co. (NASDAQ:IART) Position Lowered by Bank of New York Mellon CorpBank of New York Mellon Corp reduced its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 467,962 shares of the life scienceMarch 14, 2025 | marketbeat.comIntegra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceMarch 13, 2025 | globenewswire.comIntegra LifeSciences (NASDAQ:IART) Stock Price Down 4.3% - Here's WhyIntegra LifeSciences (NASDAQ:IART) Stock Price Down 4.3% - Should You Sell?March 13, 2025 | marketbeat.comInceptionr LLC Makes New $351,000 Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART)Inceptionr LLC purchased a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 15,491 shares of theMarch 10, 2025 | marketbeat.comIntegra LifeSciences: Light At The End Of The Tunnel, Or Another Oncoming Train? (Rating Upgrade)March 6, 2025 | seekingalpha.comFisher Asset Management LLC Decreases Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART)Fisher Asset Management LLC reduced its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 88.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 47,198 shares of the life sciences company'March 6, 2025 | marketbeat.comPrincipal Financial Group Inc. Buys 22,000 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART)Principal Financial Group Inc. grew its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 5.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 423,432 shares of the life sciences company's stock after bMarch 1, 2025 | marketbeat.comTruist Financial Remains a Hold on Integra Lifesciences (IART)February 26, 2025 | markets.businessinsider.comBTIG Remains a Hold on Integra Lifesciences (IART)February 26, 2025 | markets.businessinsider.comINTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmFebruary 25, 2025 | globenewswire.comIntegra LifeSciences sees 2025 adjusted EPS $2.41-$2.51, consensus $2.51February 25, 2025 | markets.businessinsider.comIntegra LifeSciences (NASDAQ:IART) Misses Q4 Revenue EstimatesFebruary 25, 2025 | msn.comIntegra LifeSciences Holdings Corporation 2024 Q4 - Results - Earnings Call PresentationFebruary 25, 2025 | seekingalpha.comIntegra LifeSciences (NASDAQ:IART) Updates FY25 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its FY25 earnings guidance. The company provided EPS guidance of $2.41 to $2.51 for the period, compared to the consensus estimate of $2.53.February 25, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Issues Q1 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its first quarter earnings guidance. The company provided EPS guidance of $0.40 to $0.45 for the period, compared to the consensus estimate of $0.54.February 25, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Posts Earnings Results, Beats Expectations By $0.12 EPSIntegra LifeSciences (NASDAQ:IART - Get Free Report) announced its quarterly earnings results on Tuesday. The life sciences company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.85 by $0.12. The company had revenue of $442.65 million during the quarter, compared to analyst estimates of $445.15 million. Integra LifeSciences had a positive return on equity of 12.35% and a negative net margin of 0.42%. The firm's revenue was up 11.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.89 earnings per share.February 25, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Releases FY 2025 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its FY 2025 earnings guidance. The company provided EPS guidance of 2.410-2.510 for the period, compared to the consensus estimate of 2.510. The company also issued revenue guidance of $1.7 billionillion-$1.7 billionillion, compared to the consensus estimate of $1.7 billionillion.February 25, 2025 | marketbeat.comIntegra LifeSciences (NASDAQ:IART) Updates Q1 2025 Earnings GuidanceIntegra LifeSciences (NASDAQ:IART) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of 0.400-0.450 for the period, compared to the consensus estimate of 0.560. The company also issued revenue guidance of $375.0 millionillion-$385.0 millionillion, compared to the consensus estimate of $411.7 millionillion.February 25, 2025 | marketbeat.comIntegra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Report Preview: What To ExpectFebruary 25, 2025 | finance.yahoo.comIntegra LifeSciences Holdings Corporation Non-GAAP EPS of $0.97 beats by $0.12, revenue of $442.6M misses by $2.55MFebruary 25, 2025 | seekingalpha.comIntegra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial GuidanceFebruary 25, 2025 | globenewswire.comIntegra LifeSciences (NASDAQ:IART) Stock Price Up 5.1% - Here's WhyIntegra LifeSciences (NASDAQ:IART) Trading Up 5.1% - What's Next?February 24, 2025 | marketbeat.comIntegra LifeSciences (IART) Reports Earnings Tomorrow: What To ExpectFebruary 24, 2025 | finance.yahoo.comIntegra LifeSciences Holdings Corporation Q4 2024 Earnings PreviewFebruary 24, 2025 | seekingalpha.comAccess Investment Management LLC Acquires Shares of 194,715 Integra LifeSciences Holdings Co. (NASDAQ:IART)Access Investment Management LLC acquired a new stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 194,715 shares of the life sciFebruary 23, 2025 | marketbeat.comLeeward Investments LLC MA Grows Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART)Leeward Investments LLC MA grew its position in Integra LifeSciences Holdings Co. (NASDAQ:IART - Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 405,506 shares ofFebruary 23, 2025 | marketbeat.com Remove Ads Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address IART Media Mentions By Week IART Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IART News Sentiment▼0.900.64▲Average Medical News Sentiment IART News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IART Articles This Week▼145▲IART Articles Average Week Remove Ads Get Integra LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TFX News ITGR News ATRC News ATEC News OFIX News SRDX News ANGO News ARAY News RMTI News RSLS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IART) was last updated on 4/7/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integra LifeSciences Holdings Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integra LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IART Stock Free IART Stock Alerts